Rare allelic forms of PRDM9 associated with childhood leukemogenesis

Genome Research

Volumn 23, Issue 3, 2013, Pages 419-430

  Hussin, Julie ^a,b   Sinnett, Daniel ^a,b   Casals, Ferran ^b   Idaghdour, Youssef ^b   Bruat, Vanessa ^b   Saillour, Virginie ^b   Healy, Jasmine ^b   Grenier, Jean Christophe ^b   De Malliard, Thibault ^c   Busche, Stephan ^b   Spinella, Jean Francxois ^b   Larivière, Mathieu ^b   Gibson, Greg ^d   Andersson, Anna ^e   Holmfeldt, Linda ^e   Ma, Jing ^e   Wei, Lei ^e   Zhang, Jinghui ^e   Andelfinger, Gregor ^a,b   Downing, James R ^e   Mullighan, Charles G ^e   Awadalla, Philip ^a,b   more..

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE METHYLTRANSFERASE; PRDM9 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ANIMAL CELL; ARTICLE; CHILD; CHILDHOOD B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; EXOME; GENE SEQUENCE; GENOME; HUMAN; LEUKEMOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ALLELES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSSING OVER, GENETIC; EXOME; FEMALE; GENE FREQUENCY; GENE REARRANGEMENT; GENOMIC INSTABILITY; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; INFANT; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; MEIOSIS; MICROARRAY ANALYSIS; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC;

EID: 84874615220     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.144188.112     Document Type: Article

References (79)

1. The 1000 Genomes Project Consortium. 2010. A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
2. Awadalla P, Gauthier J, Myers RA, Casals F, Hamdan FF, Griffing AR, CoteM, Henrion E, Spiegelman D, Tarabeux J, et al. 2010. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet 87: 316-324.
3. Baccichet A, Qualman SK, Sinnett D. 1997. Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res 21: 817-823. (Pubitemid 27488709)
4. Baudat F, Buard J, Grey C, Fledel-Alon A, Ober C, Przeworski M, Coop G, de Massy B. 2010. PRDM9 is a major determinant of meiotic recombination hotspots in humans and mice. Science 327: 836-840.
5. Berg IL, Neumann R, Lam KW, Sarbajna S, Odenthal-Hesse L, May CA, Jeffreys AJ. 2010. PRDM9 variation strongly influences recombination hot-spot activity and meiotic instability in humans. Nat Genet 42: 859-863.
6. Berg IL, Neumann R, Sarbajna S, Odenthal-Hesse L, Butler NJ, Jeffreys AJ. 2011. Variants of the protein PRDM9 differentially regulate a set of human meiotic recombination hotspots highly active in African populations. Proc Natl Acad Sci 108: 12378-12383.
7. Bjorge T, Cnattingius S, Lie RT, Tretli S, Engeland A. 2008. Cancer risk in children with birth defects and in their families: A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 17: 500-506. (Pubitemid 351469198)
8. Borel C, Cheung F, Stewart H, Koolen DA, Phillips C, Thomas NS, Jacobs PA, Eliez S, Sharp AJ. 2012. Evaluation of PRDM9 variation as a risk factor for recurrent genomic disorders and chromosomal non-disjunction. Hum Genet 131: 1519-1524.
9. Cann HM, de Toma C, Cazes L, Legrand MF, Morel V, Piouffre L, Bodmer J, Bodmer WF, Bonne-Tamir B, Cambon-Thomsen A, et al. 2002. A human genome diversity cell line panel. Science 296: 261-262. (Pubitemid 34303653)
10. Cartwright RA, Hussin J, Keebler JE, Stone EA, Awadalla P. 2012. A familybased probabilistic method for capturing de novo mutations from highthroughput short-read sequencing data. Stat Appl Genet Mol Biol 11. doi: 10.2202/1544-6115.1713.
11. Chi P, Allis CD,Wang GG. 2010. Covalent histonemodifications -miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10: 457-469.
12. Cohen PE, Pollack SE, Pollard JW. 2006. Genetic analysis of chromosome pairing, recombination, and cell cycle control during first meiotic prophase in mammals. Endocr Rev 27: 398-426. (Pubitemid 43848305)
13. Conrad DF, Keebler JE, DePristo MA, Lindsay SJ, Zhang Y, Casals F, Idaghdour Y, Hartl CL, Torroja C, Garimella KV, et al. 2011. Variation in genome-wide mutation rates within and between human families. Nat Genet 43: 712-714.
14. Coop G,Wen X, Ober C, Pritchard JK, Przeworski M. 2008. High-resolution mapping of crossovers reveals extensive variation in fine-scale recombination patterns among humans. Science 319: 1395-1398. (Pubitemid 351354875)
15. Crowe ML. 2005. SeqDoC: Rapid SNP and mutation detection by direct comparison of DNA sequence chromatograms. BMC Bioinformatics 6: 133.
16. Draper GJ, Sanders BM, Lennox EL, Brownbill PA. 1996. Patterns of childhood cancer among siblings. Br J Cancer 74: 152-158. (Pubitemid 26231994)
17. Easton DF, Eeles RA. 2008. Genome-wide association studies in cancer. Hum Mol Genet 17: R109-R115.
18. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. 2004. H2AX: The histone guardian of the genome. DNA Repair (Amst) 3: 959-967. (Pubitemid 38997938)
19. Ganmore I, Smooha G, Izraeli S. 2009. Constitutional aneuploidy and cancer predisposition. Hum Mol Genet 18: R84-R93.
20. Glesne D, Huberman E. 2006. Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation. Oncogene 25: 4086-4098. (Pubitemid 44024871)
21. Greaves M. 1999. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 35: 1941-1953. (Pubitemid 30026216)
22. Greaves M. 2006. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6: 193-203. (Pubitemid 43292563)
23. Greenway SC, Pereira AC, Lin JC, DePalma SR, Israel SJ, Mesquita SM, Ergul E, Conta JH, Korn JM, McCarroll SA, et al. 2009. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 41: 931-935.
24. Greer EL, Maures TJ, Ucar D, Hauswirth AG, Mancini E, Lim JP, Benayoun BA, Shi Y, Brunet A. 2011. Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans. Nature 479: 365-371.
25. Grey C, Barthes P, Chauveau-Le Friec G, Langa F, Baudat F, de Massy B. 2011. Mouse PRDM9 DNA-binding specificity determines sites of histone H3 lysine 4 trimethylation for initiation of meiotic recombination. PLoS Biol 9: e1001176.
26. Gruhn B, Taub JW, Ge Y, Beck JF, Zell R, Hafer R, Hermann FH, Debatin KM, Steinbach D. 2008. Prenatal origin of childhood acute lymphoblastic leukemia, association with birth weight and hyperdiploidy. Leukemia 22: 1692-1697.
27. Gurney JG, Severson RK, Davis S, Robison LL. 1995. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 75: 2186-2195.
28. Hassold T, Hunt P. 2001. To err (meiotically) is human: The genesis of human aneuploidy. Nat Rev Genet 2: 280-291. (Pubitemid 33674776)
29. Hassold T, Hunt P. 2009. Maternal age and chromosomally abnormal pregnancies: What we know and what we wish we knew. Curr Opin Pediatr 21: 703-708.
30. Hassold T, Hall H, Hunt P. 2007. The origin of human aneuploidy: Where we have been, where we are going. Hum Mol Genet 16: R203-R208.
31. Hayashi K, Yoshida K, Matsui Y. 2005. A histone H3 methyltransferase controls epigenetic events required for meiotic prophase. Nature 438: 374-378. (Pubitemid 41643955)
32. Healy J, Belanger H, Beaulieu P, Lariviere M, Labuda D, Sinnett D. 2007. Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood 109: 683-692. (Pubitemid 46105970)
33. Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D. 2010. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 95: 1608-1611.
34. Helleday T. 2010. Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis 31: 955-960.
35. Hinch AG, Tandon A, Patterson N, Song Y, Rohland N, Palmer CD, Chen GK, Wang K, Buxbaum SG, Akylbekova EL, et al. 2011. The landscape of recombination in African Americans. Nature 476: 170-175.
36. Hussin J, Roy-Gagnon MH, Gendron R, Andelfinger G, Awadalla P. 2011. Age-dependent recombination rates in human pedigrees. PLoS Genet 7: e1002251.
37. Idaghdour Y, CzikaW, Shianna KV, Lee SH, Visscher PM, Martin HC, Miclaus K, Jadallah SJ, Goldstein DB, Wolfinger RD, et al. 2010. Geographical genomics of human leukocyte gene expression variation in southern Morocco. Nat Genet 42: 62-67.
38. The International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437: 1299-1320.
39. Irie S, Tsujimura A, Miyagawa Y, Ueda T, Matsuoka Y, Matsui Y, Okuyama A, Nishimune Y, Tanaka H. 2009. Single-nucleotide polymorphisms of the PRDM9 (MEISETZ) gene in patients with nonobstructive azoospermia. J Androl 30: 426-431.
40. Ishisaki A, Yamato K, Hashimoto S, Nakao A, Tamaki K, Nonaka K, ten Dijke P, Sugino H, Nishihara T. 1999. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein-and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem 274: 13637-13642.
41. Jeffreys AJ, Neumann R. 2002. Reciprocal crossover asymmetry and meiotic drive in a human recombination hot spot. Nat Genet 31: 267-271.
42. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141-2144. (Pubitemid 38017950)
43. Joyce JA, Schofield PN. 1998. Genomic imprinting and cancer. Mol Pathol 51: 185-190. (Pubitemid 28394266)
44. KloostermanWP, Guryev V, van Roosmalen M, Duran KJ, de Bruijn E, Bakker SC, Letteboer T, van Nesselrooij B, Hochstenbach R, Poot M, et al. 2011. Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum Mol Genet 20: 1916-1924.
45. Kong A, Thorleifsson G, Stefansson H, Masson G, Helgason A, Gudbjartsson DF, Jonsdottir GM, Gudjonsson SA, Sverrisson S, Thorlacius T, et al. 2008. Sequence variants in the RNF212 gene associate with genomewide recombination rate. Science 319: 1398-1401. (Pubitemid 351354876)
46. Kong A, Thorleifsson G, Gudbjartsson DF, Masson G, Sigurdsson A, Jonasdottir A, Walters GB, Gylfason A, Kristinsson KT, Gudjonsson SA, et al. 2010. Fine-scale recombination rate differences between sexes, populations and individuals. Nature 467: 1099-1103.
47. Kong F, Zhu J, Wu J, Peng J, Wang Y, Wang Q, Fu S, Yuan LL, Li T. 2011. dbCRID: A database of chromosomal rearrangements in human diseases. Nucleic Acids Res 39: D895-D900.
48. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
49. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. 2010. The Genome Analysis Toolkit: A MapReduce framework for analyzing nextgeneration DNA sequencing data. Genome Res 20: 1297-1303.
50. McVean G, Myers S. 2010. PRDM9 marks the spot. Nat Genet 42: 821-822.
51. Mitelman F, Johansson B, Mertens F. 2011. Mitelman database of chromosome aberrations and gene fusions in cancer. http://cgap.nci. nih.gov/Chromosomes/ Mitelman.
52. Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, Hows JM, Navarrete C, Greaves M. 2002. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci 99: 8242-8247. (Pubitemid 34651037)
53. Morris JA, Gardner MJ. 1988. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) 296: 1313-1316.
54. Myers S, Bottolo L, Freeman C, McVean G, Donnelly P. 2005. A fine-scale map of recombination rates and hotspots across the human genome. Science 310: 321-324. (Pubitemid 41457199)
55. Myers S, Freeman C, Auton A, Donnelly P, McVean G. 2008. A common sequence motif associated with recombination hot spots and genome instability in humans. Nat Genet 40: 1124-1129.
56. Myers S, Bowden R, Tumian A, Bontrop RE, Freeman C, MacFie TS, McVean G, Donnelly P. 2010.Drive against hotspot motifs in primates implicates the PRDM9 gene in meiotic recombination. Science 327: 876-879.
57. Ondov BD, Varadarajan A, Passalacqua KD, Bergman NH. 2008. Efficient mapping of Applied Biosystems SOLiD sequence data to a reference genome for functional genomic applications. Bioinformatics 24: 2776-2777. (Pubitemid 352722623)
58. Paigen K, Szatkiewicz JP, Sawyer K, Leahy N, Parvanov ED, Ng SH, Graber JH, Broman KW, Petkov PM. 2008. The recombinational anatomy of a mouse chromosome. PLoS Genet 4: e1000119.
59. Parvanov ED, Petkov PM, Paigen K. 2010. Prdm9 controls activation of mammalian recombination hotspots. Science 327: 835.
60. Persikov AV, Osada R, Singh M. 2009. Predicting DNA recognition by Cys2His2 zinc finger proteins. Bioinformatics 25: 22-29.
61. Peters U,HutterCM,Hsu L, Schumacher FR,ContiDV,Carlson CS, Edlund CK, Haile RW,Gallinger S, Zanke BW, et al. 2012.Meta-analysis ofnewgenomewide association studies of colorectal cancer risk. HumGenet 131: 217-234.
62. Pimanda JE, Donaldson IJ, de Bruijn MF, Kinston S, Knezevic K, Huckle L, Piltz S, Landry JR, Green AR, Tannahill D, et al. 2007. The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity. Proc Natl Acad Sci 104: 840-845. (Pubitemid 46154698)
63. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909. (Pubitemid 44141658)
64. Roman E, Doyle P, Lightfoot T, Ansell P, Simpson J, Allan JM, Kinsey S, Eden TO. 2006. Molar pregnancy, childhood cancer and genomic imprinting -is there a link Hum Fertil (Camb) 9: 171-174. (Pubitemid 44480440)
65. Ross JA, Spector LG, Robison LL, Olshan AF. 2005. Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer 44: 8-12. (Pubitemid 39602559)
66. Sasaki M, Lange J, Keeney S. 2010. Genome destabilization by homologous recombination in the germ line. Nat Rev Mol Cell Biol 11: 182-195.
67. Schmiegelow K, Lausten Thomsen U, Baruchel A, Pacheco CE, Pieters R, Pombo-de-Oliveira MS, Andersen EW, Rostgaard K, Hjalgrim H, Pui CH. 2012. High concordance of subtypes of childhood acute lymphoblastic leukemia within families: Lessons from sibships with multiple cases of leukemia. Leukemia 26: 675-681.
68. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, et al. 2012. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482: 226-231.
69. Segal E, Fondufe-Mittendorf Y, Chen L, Thastrom A, Field Y, Moore IK,Wang JP, Widom J. 2006. A genomic code for nucleosome positioning. Nature 442: 772-778. (Pubitemid 44258903)
70. Segurel L, Leffler EM, Przeworski M. 2011. The case of the fickle fingers: How the PRDM9 zinc finger protein specifies meiotic recombination hotspots in humans. PLoS Biol 9: e1001211.
71. Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, Papaemmanuil E, Bartram CR, Stanulla M, Schrappe M, et al. 2010. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 42: 492-494.
72. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, GhoussainiM, Hines S, Healey CS, et al. 2010. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
73. Waanders E, Scheijen B, van der Meer LT, van Reijmersdal SV, van Emst L, Kroeze Y, Sonneveld E, Hoogerbrugge PM, Geurts van Kessel A, van Leeuwen FN, et al. 2012. The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. PLoS Genet 8: e1002533.
74. Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, Saha V, Biondi A, Greaves MF. 1999. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354: 1499-1503. (Pubitemid 29502102)
75. Winther JF, Sankila R, Boice JD, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Moller TR, Mulvihill JJ, et al. 2001. Cancer in siblings of children with cancer in the Nordic countries: A population-based cohort study. Lancet 358: 711-717. (Pubitemid 32823399)
76. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, et al. 2012. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44: 251-253.
77. Xi L, Fondufe-Mittendorf Y, Xia L, Flatow J, Widom J, Wang JP. 2010. Predicting nucleosome positioning using a duration hidden Markov model. BMC Bioinformatics 11: 346.
78. Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, Yang W, Neale G, Cox NJ, Scheet P, et al. 2011. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 43: 237-241.
79. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, et al. 2012. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481: 157-163.